Résultats français d’une enquête internationale sur les « patient-reported outcomes » électroniques réalisée par le Young Radiation Oncology Group de l’European Organization for the Research and Treatment of Cancer

Modern Radiation Therapy for Primary Cutaneous Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2015.01.008 ◽

2015 ◽

Vol 92 (1) ◽

pp. 32-39 ◽

Cited By ~ 75

Author(s):

Lena Specht ◽

Bouthaina Dabaja ◽

Tim Illidge ◽

Lynn D. Wilson ◽

Richard T. Hoppe

Keyword(s):

Radiation Therapy ◽

Radiation Oncology ◽

Oncology Group ◽

Cutaneous Lymphomas ◽

Corrigendum to “HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: Results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)” [Radiother. Oncol. 113 (2014) 317–323]

Radiotherapy and Oncology ◽

10.1016/j.radonc.2015.03.010 ◽

2015 ◽

Vol 114 (3) ◽

pp. 419

Author(s):

Fabian Lohaus ◽

Annett Linge ◽

Inge Tinhofer ◽

Volker Budach ◽

Eleni Gkika ◽

...

Keyword(s):

Radiation Oncology ◽

Locally Advanced ◽

Oropharyngeal Carcinoma ◽

Oncology Group ◽

Regional Control ◽

Explorative Study ◽

Postoperative Radiochemotherapy

Modern Radiotherapy for Extranodal Nasal-type NK/T-cell Lymphoma: Risk-adapted Therapy, Target Volume and Dose Guidelines from the International Lymphoma Radiation Oncology Group

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2021.02.011 ◽

2021 ◽

Author(s):

Shu-Nan Qi ◽

Ye-Xiong Li ◽

Lena Specht ◽

Masahiko Oguchi ◽

Richard Tsang ◽

...

Keyword(s):

T Cell ◽

Radiation Oncology ◽

Cell Lymphoma ◽

Target Volume ◽

Oncology Group ◽

Nasal Type ◽

Therapy Target ◽

Modern Radiotherapy ◽

Lymphoma Risk

A Randomised Phase III Trial of Palliative Radiotherapy (PRT) versus Concurrent Chemotherapy and PRT (C-PRT) in Patients with Good Performance Status, Locally Advanced or Metastatic NSCLC with symptoms due to intrathoracic disease who are not suitable for radical Chemo-radiotherapy: Results of the Trans-Tasman Radiation Oncology Group (TROG) 11.03 Trial

Practical Radiation Oncology ◽

10.1016/j.prro.2020.11.009 ◽

2020 ◽

Author(s):

M. Lehman ◽

A. Bernard ◽

A. See ◽

M. King ◽

M. Michael

Keyword(s):

Radiation Oncology ◽

Performance Status ◽

Locally Advanced ◽

Palliative Radiotherapy ◽

Concurrent Chemotherapy ◽

Phase Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

Metastatic Nsclc ◽

Re: Prospective analysis of the utility of 18-FDG PET in Merkel cell carcinoma of the skin: A Trans Tasman Radiation Oncology Group Study, TROG 09:03 (Journal of Medical Imaging and Radiation Oncology 62 (2018) 412-419)

Journal of Medical Imaging and Radiation Oncology ◽

10.1111/1754-9485.12792 ◽

2018 ◽

Vol 62 (5) ◽

pp. 671-671

Author(s):

Jonathan Pincus

Keyword(s):

Medical Imaging ◽

Cell Carcinoma ◽

Merkel Cell Carcinoma ◽

Radiation Oncology ◽

Fdg Pet ◽

Prospective Analysis ◽

Merkel Cell ◽

Oncology Group ◽

Oncology Group Study ◽

1045 Poster A Trans Tasman Radiation Oncology Group Phase II study of radical chemoradiation in the management of localised muscle invasive TCC of the urinary bladder (TROG 97.01)

Radiotherapy and Oncology ◽

10.1016/s0167-8140(02)83352-7 ◽

2002 ◽

Vol 64 ◽

pp. S305

Keyword(s):

Urinary Bladder ◽

Phase Ii ◽

Radiation Oncology ◽

Phase Ii Study ◽

Oncology Group ◽

Muscle Invasive

Intensity-Modulated Radiotherapy-Based Reirradiation for Head and Neck Cancer: A Multi-institutional Study by Korean Radiation Oncology Group (KROG 1707)

Cancer Research and Treatment ◽

10.4143/crt.2020.310 ◽

2020 ◽

Author(s):

Jeongshim Lee ◽

Tae Hyung Kim ◽

Yeon-Sil Kim ◽

Myungsoo Kim ◽

Jae Won Park ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Neck Cancer ◽

Radiation Oncology ◽

Intensity Modulated Radiotherapy ◽

Oncology Group ◽

Intensity Modulated ◽

Preliminary Results of a Prospective Study of Dose Reduced Short-Course CHOP followed by Involved Field Radiotherapy for Elder Patients 70 Years Old or More with Localized Aggressive non-Hodgkins Lymphomas (Japan Radiation Oncology Group; JAROG Study)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2005.07.726 ◽

2005 ◽

Vol 63 ◽

pp. S427

Author(s):

N. Shikama ◽

M. Oguchi ◽

Y. Kagami ◽

K. Isobe ◽

K. Nakamura ◽

...

Keyword(s):

Prospective Study ◽

Radiation Oncology ◽

Oncology Group ◽

Preliminary Results ◽

Elder Patients ◽

Short Course ◽

A Prospective Study ◽

Involved Field ◽

Involved Field Radiotherapy

Prospective Multi-institutional Study of Definitive Radiotherapy with High-dose-rate Intracavitary Brachytherapy in Early Stage Uterine Cervical Cancer: A Cooperative Study of Japan Radiation Oncology Group (JAROG) and Japanese Radiation Oncology Study Group (JROSG)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2010.07.305 ◽

2010 ◽

Vol 78 (3) ◽

pp. S120

Author(s):

T. Toita ◽

S. Kato ◽

Y. Niibe ◽

T. Kazumoto ◽

T. Kodaira ◽

...

Keyword(s):

Radiation Oncology ◽

Early Stage ◽

Uterine Cervical Cancer ◽

High Dose Rate ◽

Intracavitary Brachytherapy ◽

High Dose ◽

Study Group ◽

Cooperative Study ◽

Oncology Group ◽

Trans Tasman Radiation Oncology Group Cancer Research: Phase III - Muscle Invasive Bladder Cancer trial (TROG 02.03): A moral dilemma

Journal of Medical Imaging and Radiation Oncology ◽

10.1111/1754-9485.12752 ◽

2018 ◽

Vol 62 (5) ◽

pp. 668-670

Author(s):

Nirdosh K Gogna ◽

Gillian Duchesne ◽

Peter O'Brien ◽

Nigel Spry ◽

Sandra Turner ◽

...

Keyword(s):

Cancer Research ◽

Bladder Cancer ◽

Radiation Oncology ◽

Moral Dilemma ◽

Phase Iii ◽

Oncology Group ◽

Muscle Invasive Bladder Cancer ◽

Cancer Trial ◽

Muscle Invasive